Radiation-induced oesophagitis in lung cancer patients : Is susceptibility for neutropenia a risk factor?

Strahlentherapie und Onkologie

Volumn 188, Issue 7, 2012, Pages 564-567

  De Ruysscher, D ^a   Van Meerbeeck, J ^b   Vandecasteele, K ^b   Oberije, C ^a   Pijls, M ^a   Dingemans, A M C ^c   Reymen, B ^a   Van Baardwijk, A ^a   Wanders, R ^a   Lammering, G ^a   Lambin, P ^a   De Neve, W ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dysphagia; Lung cancer; Oesophagitis; Radiotherapy; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CHEMORADIOTHERAPY; DISEASE PREDISPOSITION; ESOPHAGITIS; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; RADIATION DOSE; RADIATION INJURY;

ADULT; AGED; CHEMORADIOTHERAPY; COMORBIDITY; DISEASE SUSCEPTIBILITY; ESOPHAGITIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; NEUTROPENIA; PREVALENCE; RADIATION INJURIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84862639660     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0098-z     Document Type: Article

References (20)

1. De Ruysscher D, Faivre-Finn C, Nestle U et al (2010) European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 28:5301-5310
2. Semrau S, Bier A, Thierbach U et al (2007) 6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer. Strahlenther Onkol 183:30-35 (Pubitemid 46150859)
3. Gagel B, Piroth M, Pinkawa M et al (2006) Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study. Strahlenther Onkol 182:263-269
4. Catalano G, Jereczek-Fossa BA, De Pas T et al (2005) Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity study. Strahlenther Onkol 181:363-371 (Pubitemid 40875260)
5. Mizumoto M, Sugahara S, Nakayama H et al (2010) Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol 186:482-488
6. Wolff HA, Bosch J, Jung K et al (2010) High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 186:262-268
7. Semrau R, Temming S, Preuss SF et al (2011) Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel: a phase II study. Strahlenther Onkol 187:645-650
8. Zimmermann FB, Geinitz H, Feldmann HJ (1998) Therapy and prophylaxis of acute and late radiation-induced sequelae of the esophagus. Strahlenther Onkol 174(Suppl 3):78-81 (Pubitemid 28506600)
9. Belka C (1998) Oral sucralfate administration for therapy and prevention of radiation-induced esophagitis: results of a placebo-controlled double-blind study. Strahlenther Onkol 174:333-334
10. Wurstbauer K, Merz F, Sedlmayer F (2009) Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study. Strahlenther Onkol 185:512-516
11. Ahn SJ, Kahn D, Zhou S et al (2005) Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 61:335-347 (Pubitemid 40164425)
12. Rose J, Rodrigues G, Yaremko B et al (2009) Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 91:282-287
13. Werner-Wasik M, Yorke E, Deasy J et al (2010) Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 76:86-93
14. Chapet O, Kong FM, Lee JS et al (2005) Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77:176-181 (Pubitemid 41682384)
15. Dehing-Oberije C, De Ruysscher D, Petit S et al (2010) Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiother Oncol 97:455-461
16. De Ruysscher D, Dehing C, Bremer RH et al (2007) Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18:909-916 (Pubitemid 47054090)
17. Loon J van, De Ruysscher D, Wanders R et al (2010) Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 77:329-336
18. ICRU (1993) International Commission on Radiation Units and Measurements Report 50: Prescribing, recording, and reporting photon beam therapy
19. Wurstbauer K, Weise H, Deutschmann H et al (2010) Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥80 Gy in standard fractionation. Strahlenther Onkol 186:551-557
20. Pijls-Johannesma M, Houben R, Boersma L et al (2009) High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol 91:443-448